Glenn A Jacobson

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 7

Top Topics

Chronic Obstructive Pulmonary Disease

High Resolution Mass Spectrometry

Skeletal Muscle

Top Venues

Drug testing and analysis

Sports medicine (Auckland, N.Z.)

This page only lists publications with an associated author ORCID identifier.

Publications

Morten Hostrup, Glenn A Jacobson, Kasper Eibye, Christian K Narkowicz, David S Nichols, Søren Jessen
Beta 2 -adrenergic agonist salbutamol exhibits enantioselective disposition in skeletal muscle of lean young men following oral administration. Drug testing and analysis (2024)
Nikolai Nordsborg, Glenn A Jacobson, Bejder Jacob, Dino Premilovac, Stephen M Richards, Jon Jarløv Rasmussen, Søren Jessen, Morten Hostrup
An Abductive Inference Approach to Assess the Performance-Enhancing Effects of Drugs Included on the World Anti-Doping Agency Prohibited List. Sports medicine (Auckland, N.Z.) 51 (7) (2021)
Søren Jessen, Sara Amalie Solheim, Glenn A Jacobson, Kasper Eibye, Jens Bangsbo, Nikolai Baastrup Nordsborg, Morten Hostrup
Beta2 -adrenergic agonist clenbuterol increases energy expenditure and fat oxidation, and induces mTOR phosphorylation in skeletal muscle of young healthy men. Drug testing and analysis 12 (5) (2020)
Morten Hostrup, Glenn A Jacobson, Søren Jessen, Anders Krogh Lemminger
Anabolic and lipolytic actions of beta2 -agonists in humans and antidoping challenges. Drug testing and analysis 12 (5) (2020)
Glenn A Jacobson, Morten Hostrup
The salmeterol anomaly and the need for a urine threshold. Drug testing and analysis (2020)
Morten Hostrup, Christian K Narkowicz, Sajad Habib, David S Nichols, Glenn A Jacobson
Beta2 -adrenergic ligand racemic formoterol exhibits enantioselective disposition in blood and skeletal muscle of humans, and elicits myocellular PKA signaling at therapeutic inhaled doses. Drug testing and analysis 11 (7) (2019)
Glenn A Jacobson, Morten Hostrup, Christian K Narkowicz, David S Nichols, E Haydn Walters
Enantioselective disposition of (R,R)-formoterol, (S,S)-formoterol and their respective glucuronides in urine following single inhaled dosing and application to doping control. Drug testing and analysis 11 (7) (2019)